DePEGylation studies: PEG-RBC stability in conditions consistent with massive transfusion

Area of Science:

• Transfusion Medicine
• Biomaterials Science
• Immunology

Background:

• Millions of packed red blood cells (RBCs) are transfused annually in the US.
• Unmatched Type O RBCs (UORBCs) are used in trauma, but masking RBC surface antigens may further reduce transfusion reactions.
• Antigen-masked RBCs must withstand in vivo conditions like lactic acidosis, bacteremia, and irradiation.

Purpose of the Study:

• To evaluate and validate the stability of antigen-masked RBCs for transfusion safety.
• To compare two PEGylation methods (maleimide and cyanuric chloride) for masking RBC antigens.
• To assess the stability of PEGylated RBCs under simulated massive transfusion conditions.

Main Methods:

• Two PEGylation techniques were employed: maleimide-PEGylation and cyanuric chloride-PEGylation.
• RBC PEGylation effectiveness was confirmed by masking the Rh(D) antigen.
• PEG-RBC bond stability was assessed by agglutination tests with anti-D sera before and after exposure to various conditions.

Main Results:

• Maleimide-PEG-RBCs demonstrated consistent stability across all tested conditions.
• Cyanuric chloride-PEG-RBCs remained stable during bacteremia and irradiation challenges.
• Critical concentrations of lactic acid induced dePEGylation in cyanuric chloride-PEG-RBCs.

Conclusions:

• PEGylation is a viable strategy for masking RBC antigens and potentially reducing transfusion reactions.
• Maleimide-PEGylation offers superior stability under simulated transfusion stress.
• Further research is necessary to confirm the in vivo stability and safety of cyanuric chloride-PEGylated RBCs.